158 related articles for article (PubMed ID: 21324955)
1. Male pattern baldness and the risk of prostate cancer.
Yassa M; Saliou M; De Rycke Y; Hemery C; Henni M; Bachaud JM; Thiounn N; Cosset JM; Giraud P
Ann Oncol; 2011 Aug; 22(8):1824-7. PubMed ID: 21324955
[TBL] [Abstract][Full Text] [Related]
2. Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study.
Papa NP; MacInnis RJ; English DR; Bolton D; Davis ID; Lawrentschuk N; Millar JL; Severi G; Hopper JL; Giles GG
Cancer Causes Control; 2018 Jan; 29(1):93-102. PubMed ID: 29139043
[TBL] [Abstract][Full Text] [Related]
3. Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers.
Zhou CK; Stanczyk FZ; Hafi M; Veneroso CC; Lynch B; Falk RT; Niwa S; Emanuel E; Gao YT; Hemstreet GP; Zolfghari L; Carroll PR; Manyak MJ; Sesterhenn IA; Levine PH; Hsing AW; Cook MB
Prostate; 2017 Dec; 77(16):1573-1582. PubMed ID: 28971497
[TBL] [Abstract][Full Text] [Related]
4. Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer.
Salmon C; Mesidor M; Rousseau MC; Richard H; Weiss D; Spence AR; Parent ME
Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):143-150. PubMed ID: 37851110
[TBL] [Abstract][Full Text] [Related]
5. Androgenetic alopecia and risk of prostate cancer: a systematic review and meta-analysis.
Amoretti A; Laydner H; Bergfeld W
J Am Acad Dermatol; 2013 Jun; 68(6):937-43. PubMed ID: 23395589
[TBL] [Abstract][Full Text] [Related]
6. Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case-control series of veterans.
Thomas JA; Antonelli JA; Banez LL; Hoyo C; Grant D; Demark-Wahnefried W; Platz EA; Gerber L; Shuler K; Eyoh E; Calloway E; Freedland SJ
Cancer Causes Control; 2013 May; 24(5):1045-52. PubMed ID: 23529469
[TBL] [Abstract][Full Text] [Related]
7. Relationship of early-onset baldness to prostate cancer in African-American men.
Zeigler-Johnson C; Morales KH; Spangler E; Chang BL; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):589-96. PubMed ID: 23532004
[TBL] [Abstract][Full Text] [Related]
8. Male pattern baldness in relation to prostate cancer risks: an analysis in the VITamins and lifestyle (VITAL) cohort study.
Zhou CK; Littman AJ; Levine PH; Hoffman HJ; Cleary SD; White E; Cook MB
Prostate; 2015 Mar; 75(4):415-23. PubMed ID: 25492530
[TBL] [Abstract][Full Text] [Related]
9. Early onset baldness and prostate cancer risk.
Denmark-Wahnefried W; Schildkraut JM; Thompson D; Lesko SM; McIntyre L; Schwingl P; Paulson DF; Robertson CN; Anderson EE; Walther PJ
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):325-8. PubMed ID: 10750672
[TBL] [Abstract][Full Text] [Related]
10. Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
Giles GG; Severi G; Sinclair R; English DR; McCredie MR; Johnson W; Boyle P; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):549-53. PubMed ID: 12050096
[TBL] [Abstract][Full Text] [Related]
11. Relationship between male pattern baldness and the risk of aggressive prostate cancer: an analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Zhou CK; Pfeiffer RM; Cleary SD; Hoffman HJ; Levine PH; Chu LW; Hsing AW; Cook MB
J Clin Oncol; 2015 Feb; 33(5):419-25. PubMed ID: 25225425
[TBL] [Abstract][Full Text] [Related]
12. Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey.
Hawk E; Breslow RA; Graubard BI
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):523-7. PubMed ID: 10815699
[TBL] [Abstract][Full Text] [Related]
13. Androgenic alopecia may have evolved to protect men from prostate cancer by increasing skin exposure to ultraviolet radiation.
Kabai P
Med Hypotheses; 2008; 70(5):1038-40. PubMed ID: 17910907
[TBL] [Abstract][Full Text] [Related]
14. Male pattern baldness and prostate cancer risk in a population-based case-control study.
Wright JL; Page ST; Lin DW; Stanford JL
Cancer Epidemiol; 2010 Apr; 34(2):131-5. PubMed ID: 20206591
[TBL] [Abstract][Full Text] [Related]
15. Baldness, benign prostate hyperplasia, prostate cancer and androgen levels.
Faydaci G; Bilal E; Necmettin P; Fatih T; Asuman O; Uğur K
Aging Male; 2008 Dec; 11(4):189-92. PubMed ID: 19172550
[TBL] [Abstract][Full Text] [Related]
16. 5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia.
Hayes VM; Severi G; Padilla EJ; Morris HA; Tilley WD; Southey MC; English DR; Sutherland RL; Hopper JL; Boyle P; Giles GG
Int J Cancer; 2007 Feb; 120(4):776-80. PubMed ID: 17136762
[TBL] [Abstract][Full Text] [Related]
17. Male Pattern Baldness in Relation to Prostate Cancer-Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study.
Zhou CK; Levine PH; Cleary SD; Hoffman HJ; Graubard BI; Cook MB
Am J Epidemiol; 2016 Feb; 183(3):210-7. PubMed ID: 26764224
[TBL] [Abstract][Full Text] [Related]
18. Comparative studies on level of androgens in hair and plasma with premature male-pattern baldness.
Bang HJ; Yang YJ; Lho DS; Lee WY; Sim WY; Chung BC
J Dermatol Sci; 2004 Feb; 34(1):11-6. PubMed ID: 14757277
[TBL] [Abstract][Full Text] [Related]
19. Re: Relationship between Male Pattern Baldness and the Risk of Aggressive Prostate Cancer: An Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Penson DF
J Urol; 2015 Oct; 194(4):990-1. PubMed ID: 26382778
[No Abstract] [Full Text] [Related]
20. Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use.
Sarre S; Määttänen L; Tammela TL; Auvinen A; Murtola TJ
Scand J Urol; 2016 Aug; 50(4):267-73. PubMed ID: 26927237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
